Neurofibromatosis Type 1 Patients With Epilepsy: A Comprehensive Analysis of Demographics, Comorbidities and Healthcare Outcomes

癫痫 医学 共病 儿科 人口 队列 医疗补助 内科学 医疗保健 精神科 经济增长 环境卫生 经济
作者
Nilesh Kodali,Audrey Terrany,Keshav D. Kumar,Stephen T. Chambers,S. Abu Amara,Robert A. Schwartz
出处
期刊:Experimental Dermatology [Wiley]
卷期号:33 (11)
标识
DOI:10.1111/exd.70011
摘要

ABSTRACT Neurofibromatosis Type 1 (NF1) is the most common neurocutaneous disorder in the United States. Due to a nonfunctional mutation in the NF1 gene, the disorder may initially present with café‐au‐lait spots and later numerous neurofibromas across the body. Epilepsy is a rare comorbidity of NF1, with an incidence of just 4%–7%. While abnormal electroencephalograms have been seen in up to 25% of NF1 patients, very few studies have investigated the association between epilepsy and the NF1 patient profile. This study was aimed at evaluating the associations between epilepsy and demographics, comorbidities and healthcare outcomes in NF1 patients. The 2017 National Inpatient Sample (NIS) database was retrospectively queried for patients with NF1 using ICD‐10 PCS codes. Chi‐square tests were used in univariable analysis to compare patients within this cohort with and without epilepsy. Regression analysis was used in multivariable analysis to identify comorbidities that were predictors of epilepsy and the effect of comorbidities on outcomes. 4635 patients with NF1 were identified, of which 655 (14.1%) had epilepsy and 3980 (85.9%) did not. The NF1 patient population with epilepsy was largely comprised of White males of lower household income in larger urban/teaching hospitals and who used Medicare or Medicaid. Multivariable logistic regression revealed that malignant brain neoplasms, paralytic ileus, scoliosis, pregnancy complications, paralysis, other neurological disorders, metastatic cancer, coagulopathy, drug abuse and hypertension were predictors of developing epilepsy in NF1 patients. Additionally, epilepsy in NF1 patients was associated with a shorter length of stay, lower total charges and fewer total procedures.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
张颖完成签到,获得积分10
1秒前
科研通AI2S应助科研通管家采纳,获得10
1秒前
小李李李李李完成签到,获得积分10
1秒前
1秒前
不配.应助科研通管家采纳,获得10
1秒前
1秒前
吴所畏惧发布了新的文献求助10
1秒前
Lucas应助科研通管家采纳,获得10
1秒前
NexusExplorer应助科研通管家采纳,获得10
1秒前
深情安青应助科研通管家采纳,获得10
1秒前
不配.应助科研通管家采纳,获得10
1秒前
科目三应助科研通管家采纳,获得10
1秒前
1秒前
传奇3应助科研通管家采纳,获得10
2秒前
JamesPei应助科研通管家采纳,获得10
2秒前
科研通AI2S应助科研通管家采纳,获得10
2秒前
枯木逢春应助科研通管家采纳,获得10
2秒前
wangrong应助科研通管家采纳,获得20
2秒前
2秒前
852应助每天都要哈哈哈采纳,获得10
4秒前
hy发布了新的文献求助10
4秒前
酷酷发布了新的文献求助10
4秒前
1124发布了新的文献求助10
4秒前
直率的彤完成签到 ,获得积分10
4秒前
ComposerLeven完成签到,获得积分10
5秒前
lc发布了新的文献求助10
5秒前
5秒前
昌莆发布了新的文献求助10
5秒前
哎嘿发布了新的文献求助10
5秒前
木头发布了新的文献求助10
5秒前
paparazzi221应助息衍007采纳,获得30
6秒前
宫冷雁发布了新的文献求助10
6秒前
超越针针完成签到 ,获得积分10
6秒前
打打应助吴所畏惧采纳,获得10
7秒前
id完成签到,获得积分10
7秒前
FashionBoy应助常艳艳采纳,获得100
8秒前
仇丹秋发布了新的文献求助30
8秒前
9秒前
hy完成签到,获得积分10
9秒前
zz发布了新的文献求助20
9秒前
高分求助中
Sustainability in Tides Chemistry 2000
Microlepidoptera Palaearctica, Volumes 1 and 3 - 13 (12-Volume Set) [German] 1122
Дружба 友好报 (1957-1958) 1000
The Data Economy: Tools and Applications 1000
A Dissection Guide & Atlas to the Rabbit 600
中国心血管健康与疾病报告2023(要完整的报告) 500
Ожившие листья и блуждающие цветы. Практическое руководство по содержанию богомолов [Alive leaves and wandering flowers. A practical guide for keeping praying mantises] 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3102053
求助须知:如何正确求助?哪些是违规求助? 2753346
关于积分的说明 7623434
捐赠科研通 2406027
什么是DOI,文献DOI怎么找? 1276521
科研通“疑难数据库(出版商)”最低求助积分说明 616877
版权声明 599103